Page 0013

The autoimmune diabetes Accelerator Prevention Trial (adAPT) is a new clinical

trial to find out whether an inexpensive drug can prevent Type 1 diabetes in

children at risk. It is now looking for participants, first in Scotland, and then in

the rest of the UK.

adAPT is a family study. The researchers are looking for siblings and offspring

aged between 5 and 16 years of people (their brothers, sisters or a parent) who

themselves developed T1D before the age of 25.

The trial will test whether Metformin, which is known to protect the insulin

cells from stress, can avoid the immune response that goes on to destroy them.

adAPT is sponsored by the University of Exeter, generously funded by JDRF

(Juvenile Diabetes Research Foundation) and conducted in the UK by TCTU

(Tayside Clinical Trials Unit).

www.adaptdiabetes.org

Preventing type 1 diabetes in children

Will you join us?

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028

Related Issues

powered by PageTiger